Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;2(1):23-31.
doi: 10.1007/s12307-008-0018-z. Epub 2009 Mar 18.

Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity

Affiliations

Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity

Shyamesh Kumar et al. Cancer Microenviron. 2009 Dec.

Abstract

Marek's disease (MD) of chickens is a unique natural model of Hodgkin's and Non Hodgkin's lymphomas in which the neoplastically-transformed cells over-express CD30 (CD30(hi)) antigen. All chicken genotypes can be infected with MD virus and develop microscopic lymphomas. From 21 days post infection (dpi) microscopic lymphomas regress in resistant chickens but, in contrast, they progress to gross lymphomas in susceptible chickens. Here we test our hypothesis that in resistant chickens at 21 dpi the tissue microenvironment is pro T-helper (Th)-1 and compatible with cytotoxic T lymphocyte (CTL) immunity but in susceptible lines it is pro Th-2 or pro T-regulatory (T-reg) and antagonistic to CTL immunity. We used the B2, non-MHC-associated, MD resistance/susceptibility system (line [L]6(1)/line [L]7(2)) and quantified the levels of key mRNAs that can be used to define Th-1 (IL-2, IL-12, IL-18, IFNgamma), Th-2 (IL-4, IL-10) and T-reg (TGFbeta, GPR-83, CTLA-4, SMAD-7) lymphocyte phenotypes. We measured gene expression in both whole tissues (represents tissue microenvironment and tumor microenvironment) and in the lymphoma lesions (tumor microenvironment) themselves. Gene ontology-based modeling of our results shows that the dominant phenotype in whole tissue as well as in microscopic lymphoma lesions, is pro T-reg in both L6(1) and L7(2) but a minor pro Th-1 and anti Th-2 tissue microenvironment exists in L6(1) whereas there is an anti Th-1 and pro Th-2 tissue microenvironment in L7(2). The tumor microenvironment per se is pro T-reg, anti Th-1 and pro Th-2 in both L6(1) and L7(2). Together our data suggests that the neoplastic transformation is essentially the same in both L6(1) and L7(2) and that resistance/susceptibility is mediated at the level of tumor immunity in the tissues.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Photomicrographs of kidneys at 21 dpi with MDV (see M&M), stained with “Histogene LCM frozen section staining kit” showing similarity in size of microscopic lymphoma lesions (circled) between L61 (a) and L72 (b)
Fig. 2
Fig. 2
mRNA expression profiles from kidney from MDV-infected chickens (see M&M) at 21 dpi for line 61 (resistant to gross lymphomas) and 72 (susceptible to gross lymphomas) presented as 40-mean Ct (±SEM, *=P < 0.05) at the level whole tissue (a) and microscopic lesions (b)
Fig. 3
Fig. 3
Gene ontology (GO)-based quantitative modeling shows that at the whole tissue level both the resistant L61and the susceptible L72 genotype have a pro T-reg microenvironment but also L61 has a pro Th-1 and anti Th-2 microenvironment while susceptible genotypes have the opposite (a). Microscopic lesions in both L61 and L72 have a common phenotype which is pro T-reg, pro Th-2 and anti Th-1 which is antagonistic to cytotoxic T cell mediated immunity (b)

References

    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66. doi: 10.3322/canjclin.57.1.43. - DOI - PubMed
    1. Institute NC (2007) The NCI strategic plan for leading the nation to eliminate the suffering and death due to cancer. Available via: http://strategicplan.nci.nih.gov/pdf/nci_2007_strategic_plan.pdf [cited 05/29 2008]
    1. Burgess SC, Young JR, Baaten BJ, et al. Marek’s disease is a natural model for lymphomas overexpressing Hodgkin’s disease antigen (CD30) Proc Natl Acad Sci USA. 2004;101:13879–13884. doi: 10.1073/pnas.0305789101. - DOI - PMC - PubMed
    1. Buza JJ, Burgess SC. Modeling the proteome of a Marek’s disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas. Proteomics. 2007;7:1316–1326. doi: 10.1002/pmic.200600946. - DOI - PubMed
    1. Shack LA, Buza JJ, Burgess SC. The neoplastically transformed (CD30(hi)) Marek’s disease lymphoma cell phenotype most closely resembles T-regulatory cells. Cancer Immunol Immunother. 2008;57:1253–1262. doi: 10.1007/s00262-008-0460-2. - DOI - PMC - PubMed

LinkOut - more resources